UCB - PD0053 Double-Blind, Placebo-Controlled, Randomized, 18-Month Phase 2a Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Oral UCB0599 in Study Participants With Early Parkinson's Disease

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date7/21/21 → …